1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow GnP: new trials by email Literature Review of GnP trials Research Report on GnP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma. GnP, FOLFIRINOX - Pancreatic Adenocarcinoma Resectable, Non Metastatic | Phase 2 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 42 | 2027-01-01 | 2026-09-15 |
| Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP GS, GnP - Pancreatic Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | Kochi University | 500 | 2019-01-01 | 2022-03-07 |
Gustave Roussy, Cancer Campus, Grand Paris (1) · Kochi University (1)
France (1) · Japan (1)